Pilot Study of an Acceptance and Commitment Therapy Workshop for Distress and Decision Making in Early Stage Prostate Cancer in Veterans
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Early Stage Prostate Cancer
- Sponsor
- Veterans Medical Research Foundation
- Enrollment
- 24
- Locations
- 1
- Primary Endpoint
- Number of dropouts
- Status
- Completed
- Last Updated
- 13 years ago
Overview
Brief Summary
Prostate cancer (PCa) is the most common type of cancer in men and the second leading cause of death in American men. Those diagnosed with localized prostate cancer encounter three sources of psychological distress: 1) diagnosis itself, 2) treatment decision making, and 3) the often life-altering side effects of treatment. In addition, patients who choose to undergo active surveillance which focuses on monitoring cancer in lieu of treatment, experience distress related to living with cancer. Acceptance and Commitment Therapy (ACT) is an established psychosocial intervention that has been used extensively for mental health treatment and has shown benefits for various chronic conditions. ACT is a behavioral intervention that focuses on tolerating distress and improving function. This pilot study is designed to test the feasibility of ACT for distress reduction and improved quality of life in patients recently diagnosed with early-stage, localized PCa.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Localized prostate cancer in Stages I or II
- •Ability to give informed consent
- •Age 18 to 80 years old
- •Willingness to come in for a day long intervention
Exclusion Criteria
- •Acute psychosis
- •Suicidal ideation
- •Homicidal ideation
- •Active substance abuse
Outcomes
Primary Outcomes
Number of dropouts
Time Frame: 6 months
Because this is a pilot study to determine feasibility, one of the primary outcomes is the number of participants who drop out of the active treatment arm.
Number of refusals
Time Frame: 6 months
Because this is a pilot study to determine feasibility, one of the primary outcomes is the number of participants who refuse the active treatment arm.
Secondary Outcomes
- Hospital Anxiety and Depression Scale(baseline, post intervention, 2 weeks post intervention, 3 months post intervention)
- Memorial Anxiety Scale for Prostate Cancer(baseline, post intervention, 2 weeks post intervention, 3 months post intervention)